Doximity, Inc.
DOCS
$25.02
$0.311.26%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 185.05M | 168.53M | 145.91M | 138.29M | 168.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 185.05M | 168.53M | 145.91M | 138.29M | 168.60M |
| Cost of Revenue | 18.70M | 16.43M | 15.79M | 14.47M | 14.18M |
| Gross Profit | 166.35M | 152.10M | 130.12M | 123.82M | 154.42M |
| SG&A Expenses | 59.78M | 56.94M | 48.64M | 50.17M | 51.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.08M | 103.57M | 91.23M | 89.44M | 88.59M |
| Operating Income | 71.98M | 64.96M | 54.69M | 48.85M | 80.02M |
| Income Before Tax | 80.80M | 72.94M | 64.15M | 58.39M | 89.84M |
| Income Tax Expenses | 19.24M | 10.88M | 10.83M | -4.06M | 14.64M |
| Earnings from Continuing Operations | 61.56M | 62.06M | 53.32M | 62.46M | 75.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.56M | 62.06M | 53.32M | 62.46M | 75.20M |
| EBIT | 71.98M | 64.96M | 54.69M | 48.85M | 80.02M |
| EBITDA | 74.06M | 66.73M | 55.78M | 50.08M | 81.17M |
| EPS Basic | 0.33 | 0.33 | 0.28 | 0.33 | 0.40 |
| Normalized Basic EPS | 0.27 | 0.25 | 0.21 | 0.19 | 0.30 |
| EPS Diluted | 0.31 | 0.31 | 0.27 | 0.31 | 0.37 |
| Normalized Diluted EPS | 0.25 | 0.23 | 0.20 | 0.18 | 0.28 |
| Average Basic Shares Outstanding | 187.48M | 187.71M | 187.98M | 188.36M | 187.16M |
| Average Diluted Shares Outstanding | 199.22M | 200.75M | 201.16M | 202.99M | 202.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |